Study of Safety, Tolerability and Efficacy of DFV890 in Participants With Familial Cold Auto-inflammatory Syndrome (FCAS)
Clinical trial NCT04868968 · COMPLETED
Trial details
- NCT number
- NCT04868968
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-20
- Primary completion
- 2022-12-13
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.